학술논문
A novel EGFR inhibitor acts as potent tool for hypoxia-activated prodrug systems and exerts strong synergistic activity with VEGFR inhibition in vitro and in vivo
Document Type
Article
Author
Source
In Cancer Letters 1 July 2023 565
Subject
Language
ISSN
0304-3835